International Journal of Cardiology
Volume 143, Issue 2 , Pages 124-129 , 20 August 2010

Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the Japanese general population

  • Motoyuki Nakamura

      Affiliations

    • Departments of Internal Medicine, Iwate Medical University, Morioka, Japan
    • Corresponding Author InformationCorresponding author. Department of Internal Medicine, Division of Cardiology, Iwate Medical University, 19-1 Uchimaru, Morioka, Iwate 020-8505, Japan. Tel.: +81 19 651 5111e2321; fax: +81 19 626 4406.
    • ,
  • Fumitaka Tanaka

      Affiliations

    • Departments of Internal Medicine, Iwate Medical University, Morioka, Japan
    • ,
  • Toshiyuki Onoda

      Affiliations

    • Hygiene and Preventive Medicine, Iwate Medical University, Morioka, Japan
    • ,
  • Tomohiro Takahashi

      Affiliations

    • Departments of Internal Medicine, Iwate Medical University, Morioka, Japan
    • ,
  • Masafumi Sakuma

      Affiliations

    • Departments of Internal Medicine, Iwate Medical University, Morioka, Japan
    • ,
  • Kazuko Kawamura

      Affiliations

    • Iwate Health Service Association, Morioka, Japan
    • ,
  • Kozo Tanno

      Affiliations

    • Hygiene and Preventive Medicine, Iwate Medical University, Morioka, Japan
    • ,
  • Makaski Ohsawa

      Affiliations

    • Hygiene and Preventive Medicine, Iwate Medical University, Morioka, Japan
    • ,
  • Kazuyoshi Itai

      Affiliations

    • Hygiene and Preventive Medicine, Iwate Medical University, Morioka, Japan
    • ,
  • Kiyomi Sakata

      Affiliations

    • Hygiene and Preventive Medicine, Iwate Medical University, Morioka, Japan
    • ,
  • Shinji Makita

      Affiliations

    • Departments of Internal Medicine, Iwate Medical University, Morioka, Japan
    • ,
  • Akira Okayama

      Affiliations

    • Japan Anti-Tuberculosis Association, Tokyo, Japan
    • ,
  • On behalf of the Iwate KENCO study groups

Received 26 April 2008 ,Revised 22 November 2008 ,Accepted 29 January 2009.

References 

  1. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92:843–849
  2. Rao A, Hodgson L, Pearce D, Walsh J. BNP in the community – still work to be done. Int J Cardiol. Feb 29 2008;124(2):228–230
  3. Nakamura M, Kawata Y, Yoshida H, et al. Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis. Am Heart J. 1992;124:1283–1288
  4. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209–2216
  5. Kohno M, Horio T, Yokokawa K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med. 1992;92:29–34
  6. Inoue S, Murakami Y, Sano K, et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail. 2000;6:92–96
  7. Arakawa N, Nakamura M, Aoki H, et al. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology. 1994;85:334–340
  8. Nakamura M, Endo H, Nasu M, et al. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart. 2002;87:131–135
  9. McKie PM, Burnett JC. B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities. Mayo Clin Proc. 2005;80:1029–1036
  10. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655–663
  11. Kistorp C, Raymond I, Pedersen F, et al. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005;293:1609–1616
  12. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976–982
  13. Nakamura M, Tanaka F, Sato K, et al. B-type natriuretic peptide testing for structural heart disease screening: a general population-based study. J Card Fail. 2005;11:705–712
  14. Kanda H, Kita Y, Okamura T, et al. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population?. J Hum Hypertens. 2005;19:165–172
  15. Ogawa M, Tanaka F, Onoda T, et al. A Community based epidemiological and clinical study of hospitalization of patients with congestive heart failure in northern Iwate, Japan. Circ J. 2007;71:455–459
  16. Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594–600
  17. Wang TJ, Larson MG, Levy D, et al. Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation. 2003;108:13–16
  18. Kuzuya T, Nakagawa S, Satoh J, et al. Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Prac. 2002;55:65–85
  19. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441–1446
  20. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22:6A–13A
  21. Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999;20:421–428
  22. Remes J, Reunanen A, Aromaa A, et al. Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J. 1992;13:588–593
  23. Wallen T, Landahl S, Hedner T, et al. Brain natriuretic peptide predicts mortality in the elderly. Heart. 1997;77:264–267
  24. McKie PM, Rodeheffer RJ, Cataliotti A, et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension. 2006;47:874–880
  25. Arnold JM, Yusuf S, Young J, et al. Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation. 2003;107:1284–1290
  26. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022–2031
  27. Kohno M, Minami M, Kano H, et al. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left ventricular hypertrophy. Metabolism. 2000;49:1356–1360
  28. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(09)00129-6

doi: 10.1016/j.ijcard.2009.01.076

International Journal of Cardiology
Volume 143, Issue 2 , Pages 124-129 , 20 August 2010

Article Tools

* Image Usage & Resolution